Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12883677rdf:typepubmed:Citationlld:pubmed
pubmed-article:12883677lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C0597032lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C1518051lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C1446468lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C1521996lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:12883677lifeskim:mentionsumls-concept:C0205262lld:lifeskim
pubmed-article:12883677pubmed:issue5lld:pubmed
pubmed-article:12883677pubmed:dateCreated2003-7-28lld:pubmed
pubmed-article:12883677pubmed:abstractTextThis study investigated whether it is possible to detect patients who have a high risk of metastasis and recurrence after resection of stage II Dukes' B primary colorectal cancer. Among 434 patients who underwent curative resection of primary colorectal cancer, 167 (38.5%) had Dukes' B cancer. Among them, 19 patients (11.4%) suffered from postoperative metastasis or recurrence. In 17 patients with recurrence who could be followed-up completely (recurrence group) and 17 other patients who survived for at least 5 years without recurrence (non-recurrence group), immunohistochemical staining of resected lymph nodes for cytokeratin (AE1/AE3 and CAM 5.2) was performed. AE1/AE3 was positive in 76.5% and 47.1% of the patients from the recurrence and non-recurrence groups, respectively, while CAM 5.2 was positive in 52.9% and 17.6%, respectively. There were no significant differences of either AE1/AE3 or CAM 5.2 positivity between the groups. However, the occult neoplastic cell count (mean +/- SD) floating in the lymph node sinuses was significantly higher in patients from the recurrence group who were positive for AE1/AE3 or CAM 5.2 than in patients from the non-recurrence group (6.12+/-6.00 vs. 0.59+/-0.71; p=0.0019 and 3.94+/-5.06 vs. 0.29+/-0.69; p=0.0098, respectively). These results suggest that patients with Dukes' B primary colorectal cancer who have a higher risk of recurrence can be selected by immunostaining of resected lymph nodes for cytokeratin.lld:pubmed
pubmed-article:12883677pubmed:languageenglld:pubmed
pubmed-article:12883677pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883677pubmed:citationSubsetIMlld:pubmed
pubmed-article:12883677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883677pubmed:statusMEDLINElld:pubmed
pubmed-article:12883677pubmed:issn1021-335Xlld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:MukaiMasayaMlld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:MakuuchiHiroy...lld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:NishidaTomomi...lld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:KomatsuNobuka...lld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:KIDDA AAAlld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:NakasakiHisao...lld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:SatoShinkichi...lld:pubmed
pubmed-article:12883677pubmed:authorpubmed-author:ShibaKazuakiKlld:pubmed
pubmed-article:12883677pubmed:issnTypePrintlld:pubmed
pubmed-article:12883677pubmed:volume10lld:pubmed
pubmed-article:12883677pubmed:ownerNLMlld:pubmed
pubmed-article:12883677pubmed:authorsCompleteYlld:pubmed
pubmed-article:12883677pubmed:pagination1177-81lld:pubmed
pubmed-article:12883677pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:meshHeadingpubmed-meshheading:12883677...lld:pubmed
pubmed-article:12883677pubmed:articleTitleCorrelation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.lld:pubmed
pubmed-article:12883677pubmed:affiliationDepartment of Surgery, Tokai University Oiso Hospital, Kanagawa 259-0198, Japan. colorectalmasaya@yahoo.co.jplld:pubmed
pubmed-article:12883677pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12883677pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed